title: Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
authors.affiliation: Beatson Oncology Centre, Belvidere Hospital, Glasgow.
authors.forename: J A
authors.initials: JA
authors.lastname: O'Donoghue
authors.forename: T E
authors.initials: TE
authors.lastname: Wheldon
authors.forename: J W
authors.initials: JW
authors.lastname: Babich
authors.forename: J S
authors.initials: JS
authors.lastname: Moyes
authors.forename: A
authors.initials: A
authors.lastname: Barrett
authors.forename: S T
authors.initials: ST
authors.lastname: Meller
mesh_terms: D019797:3-Iodobenzylguanidine; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001692:Biological Transport; D002648:Child; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007462:Iodobenzenes / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015233:Models, Statistical; D009447:Neuroblastoma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D011336:Probability; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine